Lo Scalpello - Journal https://www.loscalpellojournal.com/ <div class="section "> <div> <h2>Cos’è Lorem Ipsum?</h2> <p><strong>Lorem Ipsum</strong> è un testo segnaposto utilizzato nel settore della tipografia e della stampa. Lorem Ipsum è considerato il testo segnaposto standard sin dal sedicesimo secolo, quando un anonimo tipografo prese una cassetta di caratteri e li assemblò per preparare un testo campione. È sopravvissuto non solo a più di cinque secoli, ma anche al passaggio alla videoimpaginazione, pervenendoci sostanzialmente inalterato. Fu reso popolare, negli anni ’60, con la diffusione dei fogli di caratteri trasferibili “Letraset”, che contenevano passaggi del Lorem Ipsum, e più recentemente da software di impaginazione come Aldus PageMaker, che includeva versioni del Lorem Ipsum.</p> </div> </div> Pacini Editore s.r.l. en-US Lo Scalpello - Journal 0390-5276 <p><strong>AUTHORSHIP STATEMENT FORM</strong><br><strong>The corresponding author must sign the <a title="AUTHORSHIP STATEMENT FORM" href="/libraryFiles/downloadPublic/5" target="_blank" rel="noopener">Authorship Statement Form</a>, save it in .pdf and return it by uploading at our submission platform http://www.loscalpellojournal.com/.</strong></p> <p><strong>It is the policy of the Journal to correspond exclusively with one designated corresponding author. As the corresponding author, it is your responsibility to communicate with your co-authors.</strong></p> <p><strong>AUTHORSHIP RESPONSIBILITY</strong></p> <p>(1) All authors participated sufficiently in the intellectual content, analysis of data (if applicable) and writing of the article, by the criteria for authorship by the International Committee of Medical Journal Editors (http://www.icmje.org/). (2) The corresponding author certifies that the definitive version of the manuscript has been approved by all co-authors, as well as, director of the Institute or Department where the work has been carried out. (3) All persons who have made substantial contributions to the work reported in this manuscript (e.g., data collection, writing or editing assistance) but who do not fulfill the authorship criteria are named along with their specific contributions as an acknowledgement in the manuscript. The corresponding author certifies that all persons named in the acknowledgement section have provided written permission to be named. (4) All authors have reviewed the final version of the article and approve it for publication. (5) Authors must state that the article submitted has previously published, and is not under consideration or accepted for publication (in whole or in part) elsewhere nor have assigned any right or interest in the article to any third party. (6) Written permission from the authors to reproduce any material copyright elsewhere has been obtained prior to submission. (7) Authors must specify that consent has been obtained from taking part in the investigations or, in the case of paediatric patients, from the guardian/s and that they have obtained written releases from patients whose names or photographs are submitted as part of the article. (8) For reports containing original corresponding author should have full access to all the data in the study and takes responsibility for the integrity of the data accuracy of data analysis. (9) Any manuscript concerned with human subjects, medical records, or human tissue that is submitted “Lo Scalpello Journal” should comply with the principles stated in the Declaration of Helsinki “Ethical Principles Medical Research Involving ‘Human Subjects”, adopted by the 18 World Medical Assembly, Helsinki, Finland, June 1964, amended most recently by the 64 World Medical Assembly, Fontaleza, Brazil, October 2013. If the study involves human subjects or records of human patients ethical approval MUST have been obtained. The corresponding author must state ethical approval was given, by whom and the relevant Judgementʼs reference number. The manuscript should contain a statement that the work has been approved by the appropriate Ethical Committee related to the institution(s) in which the work was and that subjects gave informed consent to the work. “Lo Scalpello Journal” requires institutional Ethics Committee approval for all human studies. For retrospective studies on patientsʼ records either a statement of approval or a statement exemption from the Committee is required. <strong>Ref N° of the Ethical Committee Approval must be indicated in the <a title="AUTHORSHIP STATEMENT FORM" href="/libraryFiles/downloadPublic/5" target="_blank" rel="noopener">Authorship Statement Form</a>. The study was approved by the Institutional Ethical Committee (the Name of the Institution must indicated in the <a title="AUTHORSHIP STATEMENT FORM" href="/libraryFiles/downloadPublic/5" target="_blank" rel="noopener">Authorship Statement Form</a>) and this is clearly stated in the Methods section of the article.</strong> This statement should also be provided upon submission of the manuscript. Studies involving experiments with animals must state that their was in accordance with institution guidelines and relevant national laws. (10) The article contains no libelous or unlawful statements,<br>does not infringe the privacy of others, or contains material or instructions that might cause harm or injury. The corresponding author shall indemnify and hold the Editors and its agents and licensees harmless from any damages, costs, and expenses reasonable attorneyʼs fees and costs of settlement) resulting by reason of any claim, action, or proceeding finally sustained settled inconsistent with the foregoing warranties and representations. (11) All manuscripts are screened for plagiarism, which<br>implies immediate rejection. Suspected plagiarism is handled in accordance with the COPE flowcharts (http://publicationethics.org/resources/flowcharts).<br>Every author or co-author of any article published in this Journal is solely responsible for the contents of the article, for the statement made in their paper and for the material sent. Every author or co-author needs to fully comply with the Regulation 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard processing of personal data and on the free movement of such data, and repealing Directive 95/46/EC (General Data Protection Regulation): “<em>Article 9. Processing of personal data revealing racial or ethnic origin, political opinions, religious or philosophical beliefs, or trade union membership, and the processing of genetic data, biometric data for the purpose of uniquely identifying natural person, data concerning health or data concerning a natural person's sex life or sexual orientation shall be prohibited</em>”.</p> <p><strong>PRIVACY POLICY STATEMENT.</strong> Personal data of the author will be managed by the Publisher in full compliance with the legislation on the privacy protection (art. 13 of EU regulation 2016/6799). According to articles 15-20 of the GDPR, any author may exercise specific rights, including the right to obtain access to personal data in an intelligible form, correct, update or them. Authors will also have the right to obtain from the Publisher limitation of data processing, and may also oppose to data processing legitimate reasons. In the case that the author believes that processing of his/her own personal data infringes GDPR regulation, he/she has the right to make a complaint to the Supervisory Authority for the Protection of Personal Data to art. 77 of the GDPR. Controller of data processing, according to art. 4.1.7 of the GDPR, is Mrs. Donatella Paoletti for Pacini Srl, with registered office in 56121 Pisa, Italy, Via A Gherardesca n. 1. To exercise the rights of GDPR referred to in paragraph same article, you can address any request for information to the following e-mail: privacy@pacinieditore.it. For further information refer to the website: <a href="https://www.loscalpellojournal.com/privacy-policy" target="_blank" rel="noopener">https://www.loscalpellojournal.com/privacy-policy</a></p> <p><strong>FINANCIAL DISCLOSURE</strong>. All authors must state any information that may be perceived as potential conflict of interest. must disclose all their affiliations including any relevant personal or institutional financial involvement (employment by an concern, consultancies, honoraria, speakers bureau, stock ownership or options, expert testimony, grants received or pending, membership on a standing advisory council or committee, a seat on the board of directors, or being publicly associated with company or its products, royalties, donation of medical equipment, etc.) with any organization that to any authorʼs knowledge direct interest, particularly a financial interest, in the subject matter or materials discussed. This declaration will be treated Editor as confidential while the paper is under review, and will not be made known to Reviewers. Please indicate on the <a title="AUTHORSHIP STATEMENT FORM" href="/libraryFiles/downloadPublic/5" target="_blank" rel="noopener"><strong>Authorship Statement Form</strong></a> whether or not you have or may have such a conflict of interest regarding the content of this article and nature of it.</p> <p><strong>COPYRIGHT TRANSFER AGREEMENT</strong>. (a) Authors assign to “Lo Scalpello Journal”, all copyright in and to including but not limited to the right to publish, republish, transmit, sell, distribute and otherwise use the article in whole or electronic and print editions of the Journal and in derivative works throughout the world, in all languages and in all media expression now known or later developed, and to license or permit others to do so. (b) The authors retain all proprietary rights, than copyright, such as patent rights. The authors retain the right to reuse any portion of the work, without charge, in personal compilations or other publications consisting solely of the author(sʼ) own works, including the author(sʼ) personal web home and to make copies of all or part of the Work for the author(sʼ) use for lecture or classroom purposes. The corresponding declares that any person named as co-author of the article is aware of the submission and has agreed to being so named. corresponding author accepts responsibility for releasing this material on behalf of any and all co-authors. The corresponding declares that statements and opinions given in the article are the expression of the authors. Responsibility for the content article rests upon the authors.</p> Two-peg versus flat tibial tray design in cemented unicompartmental knee arthroplasty https://www.loscalpellojournal.com/article/view/295 <p><strong>Objective</strong>. Suboptimal fixation of the tibial component is one of the main factors leading to aseptic loosening in unicompartmental knee arthroplasty (UKA). Improvements in primary fixation in cemented UKA have been suggested to be a key issue for long-term survival. In this context, it has been questioned whether specific implant design features influence interface strength, lowering aseptic loosening and post-operative pain rates. The aim of this study is to compare two different tibial tray designs in cemented UKA in terms of clinical outcome, failures, implant survival, and complications. <br><strong>Materials and methods.</strong> This is a prospective consecutive study of two different tibial component fixation in 100 cemented UKA. 50 patients received a flat cemented tibial tray design, and 50 a two-peg cemented tibial component UKA. Both groups were similar in terms of age, sex, comorbidities, and BMI. <br><strong>Results</strong>. No significant difference was found in clinical outcomes and overall failure rates. In the flat tray group, the mean preoperative KSS was 57.2, which increased at 1-year follow-up after surgery to 92.28, and remained stable at the 3 and 6 year control visits. In parallel, the mean pre-operative KOOS of 59 increased to 87.20. The mean preoperative KSS score in the 2 pegs group was 56.8 and the mean KOOS 58.1. At 1-year follow-up the KSS score increased to 94.1 and the KOOS score to 89.22, remaining stable at the 3- and 6-year follow-ups. Two-peg tibial component showed a significantly lower rate of persistent pain on the tibial side, 8% of patients at 1 year follow-up and 2% at 2 years, compared to 20% at 1 year and 6% at 2-year follow-up in the flat tray group (p &lt; 0.05). In both groups, patients with pain at the 2-year control, 4 patients in total, still complained of mild and intermittent pain, VAS 1 to 2, at the 6 year visit. There was also a lower incidence of radiolucent lines compared to flat design prosthesis, none versus 6 at 3-yeas radiographic control. Radiolucent lines were not related to pain. No difference was detected regarding range of motion between the two groups. <br><strong>Conclusions</strong>. This study reveals that the clinical results and failure rates arising from the use of two different tibial components, one flat and one with 2 pegs, are similar. However, a lower rate of pain and radiolucent lines are detected on the tibial side with the use of a two-peg tibial component design. This outcome could denote a better fixation of the 2 peg metal-backed tibial component implant.</p> Vincenzo Sessa Umberto Celentano Copyright (c) 2023 © Ortopedici Traumatologi Ospedalieri d’Italia (O.T.O.D.i.) https://creativecommons.org/licenses/by-nc-nd/4.0 2023-12-21 2023-12-21 37 103 108 10.36149/0390-5276-295 Heterotopic ossification after total hip arthroplasty: a narrative review of modifiable risk factors https://www.loscalpellojournal.com/article/view/299 <p><span class="TextRun SCXW179128627 BCX0" lang="EN-GB" xml:lang="EN-GB" data-contrast="none"><span class="NormalTextRun SCXW179128627 BCX0">Total hip arthroplasty is a popular procedure for treatment of </span><span class="NormalTextRun SCXW179128627 BCX0">osteoarthritis</span><span class="NormalTextRun SCXW179128627 BCX0"> of the hip, aseptic necrosis of femoral head</span><span class="NormalTextRun SCXW179128627 BCX0"> and femur neck and head fractures. It is </span><span class="NormalTextRun SCXW179128627 BCX0">a highly successful</span><span class="NormalTextRun SCXW179128627 BCX0"> procedure with high satisfaction of the patients, however sometimes the success rate might be limited</span><span class="NormalTextRun SCXW179128627 BCX0"> by the development of heterotopic ossification around the hip. This narrative review aims to </span><span class="NormalTextRun SCXW179128627 BCX0">analyse</span><span class="NormalTextRun SCXW179128627 BCX0"> the peri-operative modifiable risk factors</span><span class="NormalTextRun SCXW179128627 BCX0"> for heterotopic ossification formation</span> <span class="NormalTextRun SCXW179128627 BCX0">to help especially young surgeons in choos</span><span class="NormalTextRun SCXW179128627 BCX0">ing the correct way to prevent </span><span class="NormalTextRun SCXW179128627 BCX0">this problematic complication</span><span class="NormalTextRun SCXW179128627 BCX0">.</span><span class="NormalTextRun SCXW179128627 BCX0"> The search was conducted on PubMed and the final set includes </span><span class="NormalTextRun SCXW179128627 BCX0">32 academic articles. </span><span class="NormalTextRun SCXW179128627 BCX0">Results are grouped in five paragraphs: </span><span class="NormalTextRun SCXW179128627 BCX0">nonsteroidal anti-inflammatory drug</span><span class="NormalTextRun SCXW179128627 BCX0">s and radiation therapy, </span><span class="NormalTextRun SCXW179128627 BCX0">surgical approach,</span><span class="NormalTextRun SCXW179128627 BCX0"> surgical time</span><span class="NormalTextRun SCXW179128627 BCX0"> and </span><span class="NormalTextRun SCXW179128627 BCX0">use of drainage</span><span class="NormalTextRun SCXW179128627 BCX0"> and </span><span class="NormalTextRun SCXW179128627 BCX0">type of implant.</span> <span class="NormalTextRun AdvancedProofingIssueV2Themed SCXW179128627 BCX0">In</span> <span class="NormalTextRun AdvancedProofingIssueV2Themed SCXW179128627 BCX0">light of</span><span class="NormalTextRun SCXW179128627 BCX0"> this </span><span class="NormalTextRun SCXW179128627 BCX0">narrative review</span><span class="NormalTextRun SCXW179128627 BCX0">, we suggest the systematic use of NSAIDs as preventive therapy, the adoption of minimally invasive surgical approaches</span> <span class="NormalTextRun SCXW179128627 BCX0">aiming to reduce both surgical time and soft tissue </span><span class="NormalTextRun SCXW179128627 BCX0">damage</span> <span class="NormalTextRun SCXW179128627 BCX0">and</span> <span class="NormalTextRun SCXW179128627 BCX0">we discourage the use of drainage</span><span class="NormalTextRun SCXW179128627 BCX0"> a</span><span class="NormalTextRun SCXW179128627 BCX0">nd short stems in total hip arthroplasty.</span></span><span class="EOP SCXW179128627 BCX0" data-ccp-props="{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:360}">&nbsp;</span></p> Pietro Spolettini Jacopo Ambrosini Nicholas Elena Carlo Ambrosini Stefano Giaretta Copyright (c) 2023 © Ortopedici Traumatologi Ospedalieri d’Italia (O.T.O.D.i.) https://creativecommons.org/licenses/by-nc-nd/4.0 2024-01-30 2024-01-30 37 109 113 10.36149/0390-5276-299 Fixation options in Felix type IIIA periprosthetic tibial fractures: our experience and review of literature https://www.loscalpellojournal.com/article/view/298 <p><strong>Objective</strong>. Periprosthetic tibial fractures are rare injuries with few studies in the literature. With an increasing number of total knee arthroplasties performed, these injuries are expected to become more common. These fractures are difficult to treat due to complex fracture morphology, high proportions of injuries associated, and the variability of injury patterns. The aim of this work is to report our experience and results in the fixation of Felix type IIIA periprosthetic tibial fractures. <br><strong>Methods</strong>. We treated by osteosynthesis three patients who sustained a Felix type IIIA periprosthetic tibial fracture using three different devices. Patients were clinically and radiographically followed up at 1, 3, 6, and 12 months from the surgery. <br><strong>Results</strong>. All patients had a good clinical and radiographic outcome with almost complete recovery of joint function. Complete bone healing was radiographically seen on average 6 months after surgery. No signs of infection were observed. <br><strong>Conclusions</strong>. Although the incidence of periprosthetic tibial fractures is growing, evidence- based guidelines for their treatment are still lacking. We report our experience in the treatment of these complex fractures, but larger studies in this area are needed to better guide our knowledge and choices of treatment.</p> Paolo Bastia Lapo De Luca Simone Lazzeri Luigi Branca Vergano Copyright (c) 2023 © Ortopedici Traumatologi Ospedalieri d’Italia (O.T.O.D.i.) https://creativecommons.org/licenses/by-nc-nd/4.0 2023-12-19 2023-12-19 37 114 118 10.36149/0390-5276-298 Case report of closed reduction of an irreducible postero-lateral knee dislocation and review of the literature https://www.loscalpellojournal.com/article/view/297 <p><strong>Objectives</strong>. Knee dislocation is an uncommon injury. This study aims to describe the treatment of a postero-lateral knee dislocation. <br><strong>Case presentation</strong>. We report on a 71-year-old man, who accessed the emergency department for direct-rotational trauma to his left knee. X-rays showed a postero-lateral knee dislocation associated with multiple traction fractures. <br><strong>Results</strong>. Under fluoroscopy a closed reduction was performed in the operating room by flexing the knee to 120°, internal rotation of the lower extremity and valgus stress at the distal thigh. Due to the instability, a knee-spanning external fixation at 30° of flexion was performed. Post-operatively the patient fell, causing disassemblation of the external fixator and recurrence of medial knee dislocation. Only a partial re-alignment was obtained with a second closed reduction and spanning. The knee was later reconstructed with hinged knee prosthesis and the deformity was corrected. <br><strong>Conclusions</strong>. This case report is the third instance of closed reduction for a postero-lateral knee dislocation. Furthermore, this case report highlights possible complications of the treatment of this rare injury and how definitive treatment must be tailored to the patient’s age, function, clinical conditions, radiological findings and joint stability.</p> Marco Focaccia Marco Ramella Antonio Vilardi Carlo Impallomeni Copyright (c) 2023 © Ortopedici Traumatologi Ospedalieri d’Italia (O.T.O.D.i.) https://creativecommons.org/licenses/by-nc-nd/4.0 2024-01-30 2024-01-30 37 119 123 10.36149/0390-5276-297 Ultrasound-guided lumbar facet injections. Technique and literature review https://www.loscalpellojournal.com/article/view/294 <p class="western" lang="en-US" align="justify">This review examines the current state-of-the-art of ultrasound-guided lumbar facet joint injections (FJI), highlighting its emergence as a novel and increasingly successful approach. The literature underscores its growing popularity owing to practical advantages such as low cost, absence of radiation, real-time needle visualisation and tracking, and a low rate of complications. The procedure serves a dual purpose: as a diagnostic test for facet joint syndrome-related low back pain and as a therapeutic intervention for pain alleviation. Ultrasound guidance is particularly advantageous when coupled with needle guidance systems, ensuring precise needle direction for deep structure penetration with heightened accuracy. In conclusion, ultrasound-guided lumbar FJI is a non-invasive, cost-effective, and radiation- free alternative to intrarticular injections guided by fluoroscopy and computed tomography. This comprehensive review aims to serve as an insightful resource for practitioners, providing valuable insights into the procedural nuances and clinical benefits of this procedure.</p> Yuri Lepenne Vincenzo Zakaria Maria Vittoria Bausano Vittoria Chiarpenello Paolo Felisaz Michaela Cellina Elena Virgina Colombo Piermario Luigi Tosco Giovanni Zatti Roberto Maria Capelli Copyright (c) 2023 © Ortopedici Traumatologi Ospedalieri d’Italia (O.T.O.D.i.) https://creativecommons.org/licenses/by-nc-nd/4.0 2024-01-30 2024-01-30 37 124 131 10.36149/0390-5276-294 Healthcare-associated infections in an orthopaedic setting: a multidisciplinary approach https://www.loscalpellojournal.com/article/view/300 <p>Healthcare-associated infections (HAIs) are a significant problem in healthcare facilities, resulting in longer hospital stays, additional costs and inconvenience for patients. Surgical site infections are one of the most common types of HAIs. In this context, orthopaedics appears to be the surgical area that is most involved in claims for HAIs. This narrative review explores the landscape of HAIs, their prevalence, associated adverse events, preventive measures and overall impact by providing an overview of infections in elective orthopaedic surgery. In summary, a significant proportion of surgical site infections can be prevented by a comprehensive, multidisciplinary approach.</p> Liana Miccolis Francesco Paolo De Siena Michele Serpentino Matteo Rigoni Sofia Zanovello Sara Mondino Copyright (c) 2023 © Ortopedici Traumatologi Ospedalieri d’Italia (O.T.O.D.i.) https://creativecommons.org/licenses/by-nc-nd/4.0 2024-01-30 2024-01-30 37 132 136 10.36149/0390-5276-300 Mini-invasive technique for Achilles tendon rupture: BarTur technique. A new simple and inexpensive technique https://www.loscalpellojournal.com/article/view/292 <p><strong>Objective</strong>. The aim of this study is to describe and evaluate clinical and subjective outcomes of our mini-invasive technique: the “BarTur technique”, and to consider it as a viable surgical treatment option for Achilles tendon rupture (ATR). <br><strong>Methods</strong>. We included 69 patients who underwent the Bartur technique from January 2019 to December 2022. We analyzed the rate of satisfaction, quality of life and functional clinical outcomes with a minimum of 6 months of follow-up. <br><strong>Results</strong>. The final study population consisted of 69 patients with a mean age of 49 years and a mean follow-up of 16.5 months. During follow‐up no complications were observed, and no workers changed their job. They returned at work after a mean of 3.2 months. Only 27 patients returned to practice sport after a mean of 8.8 months; 21 of these changed the type of sport. Our population had good results in clinical scores (92.6% AOFAS, 92.6% FAAM, 4.7% FFI, 91.4 ATRS); their satisfaction was 8.5 and they had a good quality of life (95 EQ-5L).<br><strong>Conclusions</strong>. The BarTur method is a simple, inexpensive and good option for surgical treatment of ATR. This treatment offers a lower risk of complications, high rate of satisfaction, good clinical outcomes and a few limitations in sports.</p> Marco Baglioni Rinaldo Tambasco Luca Turelli Copyright (c) 2023 © Ortopedici Traumatologi Ospedalieri d’Italia (O.T.O.D.i.) https://creativecommons.org/licenses/by-nc-nd/4.0 2024-01-30 2024-01-30 37 137 143 10.36149/0390-5276-292